Desmoplastic Small Round Cell Tumor: A Case Report Rebaz Haji Ali, Shano M. Ali, Rawa M. Ali, Soran H. Tahir, Shad Nasir Mohammed, Dana T. Gharib, Zana Baqi Najmadden, Hoshmand R. Asaad and 2 more Introduction Desmoplastic small round cell tumor (DSRCT) is an ultra-rare and highly aggressive mesenchymal tumor that primarily affects the peritoneum, and to a lesser extent, the visceral organs in the abdominal cavity. This study presents a case of a patient who has been diagnosed with DSRCT and has been managed… 2023 1,201 reads 0 citations doi:10.58742/etbs9n84 Full text PDF XML Read abstract — read the abstract for Desmoplastic Small Round Cell Tumor: A Case Report Case Reports Desmoplastic Small Round Cell Tumor: A Case Report Rebaz Haji Ali, Shano M. Ali, Rawa M. Ali, Soran H. Tahir, Shad Nasir Mohammed, Dana T. Gharib, Zana Baqi Najmadden, Hoshmand R. Asaad and 2 more IntroductionDesmoplastic small round cell tumor (DSRCT) is an ultra-rare and highly aggressive mesenchymal tumor that primarily affects the peritoneum, and to a lesser extent, the visceral organs in the abdominal cavity. This study presents a case of a patient who has been diagnosed with DSRCT and has been managed with VAC-IE chemotherapy. Case presentationA 43-year-old male presented with a complaint of epigastric pain for 20 days but no other clinical symptoms. A CT scan and an abdominal ultrasound showed multiple lesions in the peritoneum, and biopsies were taken from all the sites. Histological analysis revealed nests of small blue round cells surrounded by an abundant stroma. Immunohistochemistry results confirmed the disease to be a desmoplastic small round cell tumor. ConclusionThis disease is yet to be fully understood, and the response of our case to VAC-IE chemotherapy has shown promising outcomes. This form of treatment can be further studied to establish and help in finding a treatment with a better prognosis. Keywords DSRCT · VAC-IE chemotherapy · Rare abdominal metastasis All subjects Barw Medical Journal. 2023 Read the article PDF XML
